Richard E. Higgs

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19

Robert Gottlieb, Ajay Nirula, Peter Chen et al. · JAMA · 2021 · 947 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +15

Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides

Milla Koistinaho, Suizhen Lin, Xin Wu et al. · Nature Medicine · 2004 · 560 citations

Life Sciences, Neurobiology, Neuroscience +16

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett et al. · Science Translational Medicine · 2021 · 497 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang et al. · Cell Reports · 2022 · 464 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Characteristic Physical Properties and Structural Fragments of Marketed Oral Drugs

Michal Vieth, Miles G. Siegel, Richard E. Higgs et al. · Journal of Medicinal Chemistry · 2003 · 356 citations

Pharmacy, Pharmacokinetics, Pharmacology +14